Overall, across the 25 countries as a whole, people are more likely to think things in their country are off on the wrong track (61%), than headed in the right direction (39%). Most pessimistic are Mexico and France, 89% of whom think things are going wrong, and Brazil (84%).
The majority (62%) of people around the world think things in their country are on the wrong track.
Unemployment currently occupies the top spot for global concern with 38% saying this.
Deployed successfully, social listening can accelerate insight generation from any kind of text data: web forums, social media sites, survey verbatims, internal data, and much more.
Cancer patients who otherwise would shy away from visiting the gym because of an altered appearance and lack of confidence are thriving as a result of an innovative 12-week exercise program.
Ipsos Healthcare has launched its Nonalcoholic Steatohepatitis (NASH) Therapy Monitor in the US and EU5 initially – France, Germany, Italy, Spain, and UK – with other markets available on demand.
Ipsos Healthcare – the global healthcare division of Ipsos – has launched the syndicated PD-L1 Testing Monitor, a timely addition to the Ipsos Oncology Molecular Diagnostics Portfolio.
Non-alcoholic Steatohepatitis, or NASH, is a liver disease characterized by rising prevalence, low diagnosis and a lack of therapies approved for treatment. All of these factors combine to make NASH a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. Accordingly, the race is now on among several pharma companies to develop the first effective pharmacotherapy to treat NASH.
